Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2017 · 10-Q
Revenue$1.62M$1.62M+150.4% vs Q2 2016 Net Income$547.00K$547.00KN/M vs Q2 2016 EPS Diluted$0.01$0.01N/M vs Q2 2016 Gross Profit$1,151,763+166.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived-$92,069N/M Free Cash Flowderived-$2,051,568— Margins · derivedGross margin71.1%+4.2 pt vs Q2 2016
Operating margin37.1%+21.9 pt vs Q2 2016
Net margin33.7%+41.6 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end